Ludovica Leo
Overview
Explore the profile of Ludovica Leo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazzaschi G, Marrocchio C, Moron Dalla Tor L, Leo L, Balbi M, Milanese G, et al.
Clin Cancer Res
. 2024 Dec;
PMID: 39670974
Purpose: To uncover the underpinnings of acquired resistance (AR) to immunotherapy (IO), we determined whether distinctive clinico-pathological, radiomic and peripheral blood (PB) immune-inflammatory features reflect oligo- and systemic (sys)-AR in...
2.
Balbi M, Mazzaschi G, Leo L, Moron Dalla Tor L, Milanese G, Marrocchio C, et al.
J Thorac Imaging
. 2024 Aug;
40(1.
PMID: 39188157
Purpose: This study aims to determine whether longitudinal changes in CT radiomic features (RFs) and systemic inflammatory indices outperform single-time-point assessment in predicting survival in advanced non-small cell lung cancer...
3.
Marrocchio C, Leo L
Radiol Imaging Cancer
. 2024 Jan;
6(1):e249003.
PMID: 38276903
No abstract available.
4.
Paladini I, Schiro S, Ledda R, Leo L, Milanese G, Epifani E, et al.
Oral Maxillofac Surg
. 2024 Jan;
28(2):809-818.
PMID: 38261079
Purpose: To evaluate the clinical and aesthetic outcome of percutaneous injection of sclerosant agents to treat head and neck cystic malformations (HNCM) and to assess their recurrence rate based on...
5.
Ventura L, Gnetti L, Milanese G, Rossi M, Leo L, Cattadori S, et al.
Arch Bronconeumol
. 2023 Apr;
59(7):418-426.
PMID: 37032196
Introduction: This study aimed to evaluate a potential relationship between the diffusing capacity of the lung for carbon monoxide (DLCO) and the aggressiveness of lung adenocarcinoma (ADC). Methods: Patients who...
6.
Pennati F, Leo L, Ferrini E, Sverzellati N, Bernardi D, Stellari F, et al.
Sci Rep
. 2023 Mar;
13(1):4462.
PMID: 36932122
Experimental in-vivo animal models are key tools to investigate the pathogenesis of lung disease and to discover new therapeutics. Histopathological and biochemical investigations of explanted lung tissue are currently considered...
7.
Negri F, Bottarelli L, Pedrazzi G, Maddalo M, Leo L, Milanese G, et al.
Front Oncol
. 2023 Mar;
13:1132564.
PMID: 36925919
Introduction: The Notch intracellular domain (NICD) and its ligands Jagged-1(Jag1), Delta-like ligand (DLL-3) and DLL4 play an important role in neoangiogenesis. Previous studies suggest a correlation between the tissue levels...
8.
Grandi A, Ferrini E, Mecozzi L, Ciccimarra R, Zoboli M, Leo L, et al.
Am J Physiol Lung Cell Mol Physiol
. 2023 Jan;
324(2):L211-L227.
PMID: 36625471
The development of new drugs for idiopathic pulmonary fibrosis strongly relies on preclinical experimentation, which requires the continuous improvement of animal models and integration with in vivo imaging data. Here,...
9.
Schiro S, Milanese G, Maddalo M, Ziglioli F, Maestroni U, Manna C, et al.
Eur Radiol
. 2022 Dec;
33(4):2975-2984.
PMID: 36512046
Objectives: To test reproducibility and predictive value of a simplified score for assessment of extraprostatic tumor extension (sEPE grade). Methods: Sixty-five patients (mean age ± SD, 67 years ± 6.3)...
10.
Vincenzi E, Fantazzini A, Basso C, Barla A, Odone F, Leo L, et al.
Respir Res
. 2022 Nov;
23(1):308.
PMID: 36369209
Idiopathic pulmonary fibrosis, the archetype of pulmonary fibrosis (PF), is a chronic lung disease of a poor prognosis, characterized by progressively worsening of lung function. Although histology is still the...